文献速递心外重症与机械循环支持

血型与体型对IABP或Impella桥接心脏移植成功的影响

The impact of blood type and body size on successful bridging to heart transplantation using intra-aortic balloon pump or surgically implanted microaxial left ventricular assist device.
PubMed 文献 · J Thorac Cardiovasc Surg · 2024-09-25

该研究基于UNOS登记数据,比较O型血与非O型血心脏移植候选者使用Impella 5.0/5.5、主动脉内球囊反搏(IABP)或HeartMate 3左心室辅助装置桥接的1年 listing 后生存率。结果显示O型血候选者使用Impella或IABP与更差的 listing 后生存相关,但正常身高且非肥胖者该风险降低。

要点

  • O型血候选者使用Impella或IABP桥接较HeartMate 3增加 listing 后死亡风险。
  • 正常身高且非肥胖的O型血候选者使用Impella或IABP风险未显著增加。
  • 非正常身高或肥胖的O型血候选者使用Impella或IABP死亡风险显著升高。

核心结论

  • 在当前器官分配时代,O型血候选者使用Impella或IABP桥接较持久左心室辅助装置增加 listing 后死亡风险。
  • 正常身高和体型者中该风险效应减弱。

研究设计与样本

  • 回顾性队列研究,查询UNOS登记库,纳入接受Impella、IABP或HeartMate 3支持的成人首次心脏移植候选者(排除透析),共2942例(Impella 214例,IABP 1326例,HeartMate 3 1402例)。

主要发现

  • 非O型血候选者中上述关联较弱。

临床怎么用

  • O型血心脏移植候选者选择桥接策略时,应优先考虑持久左心室辅助装置而非Impella或IABP。
  • 对于O型血正常身高且非肥胖候选者,Impella或IABP可作为桥接选项,但需个体化评估。

局限性

  • 回顾性登记研究,可能存在选择偏倚和未测量混杂因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Waitlist time for United Network for Organ Sharing Status 2 heart transplant candidates has steadily increased. We compared a bridging strategy using either the Impella 5.0/5.5 ("Impella") or intra-aortic balloon pump with a durable left ventricular assist device in patients with blood type O stratified by body habitus. METHODS: The United Network for Organ Sharing registry was queried for adults listed for de novo heart transplantation (without dialysis) supported by the Impella, an intra-aortic balloon pump, or the HeartMate 3 left ventricular assist device. The primary outcome was 1-year postlisting survival, defined as the sum of waitlist time and post-heart transplant survival time if the candidate underwent heart transplantation. RESULTS: In total, 2942 candidates were included (Impella: 214; intra-aortic balloon pump: 1326; HeartMate 3: 1402). Listing with the Impella or intra-aortic balloon pump was associated with worse postlisting survival compared with the HeartMate 3 left ventricular assist device in type O candidates (Impella: hazard ratio, 2.90 [95% CI, 1.48-5.67], P = .002; intra-aortic balloon pump: hazard ratio, 2.42 [95% CI, 1.59-3.68], P < .001) but less so in non-type O candidates. Further analysis of type O candidates demonstrated that the Impella and intra-aortic balloon pump were associated with a lower risk of postlisting mortality among those with normal height (25-75th percentile) and nonobese (body mass index <30) (Impella: hazard ratio, 1.78 [95% CI, 0.61-5.18], P = .292; intra-aortic balloon pump: hazard ratio, 1.28 [95% CI, 0.67-2.45], P = .455); among those not of normal height and nonobese, the Impella and intra-aortic balloon pump were associated with an elevated risk of postlisting mortality (Impella: hazard ratio, 3.65 [95% CI, 1.68-7.95], P = .001; intra-aortic balloon pump: hazard ratio, 3.01 [95% CI, 1.95-4.67], P < .001). CONCLUSIONS: Blood type O candidates listed with the Impella or intra-aortic balloon pump are at increased risk of postlisting mortality compared with a durable left ventricular assist device in the current organ allocation era. These effects are diminished among those with normal height and body habitus.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Nordan T, Keshk M, Hackmann A, et al. The impact of blood type and body size on successful bridging to heart transplantation using intra-aortic balloon pump or surgically implanted microaxial left ventricular assist device. J Thorac Cardiovasc Surg. 2024. PMID: 39332521. doi:10.1016/j.jtcvs.2024.09.028

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。